IGF1 and type 2 diabetes mellitus: Recent studies have demonstrated that lower baseline IGF1 levels predict the subsequent development of impaired glucose tolerance (IGT), type 2 diabetes, cardiovascular disease and a worsening state of insulin-resistance.